Artificial Pancreas Reduces Highs & Hypos
The average person with diabetes is outside the optimum range of blood glucose levels more than 60% of the time.
By Jenny Gunton & Nigel Greenwood
Researchers hope that within 3 years new insulin pump software may be available to replace the functions of pancreatic beta-cells lost in Type 1 diabetes.
Jenny Gunton is Group Leader of the Diabetes and Transcription Factors Group at the Garvan Institute of Medical Research. Nigel Greenwood is Honorary Senior Fellow in the University of Queensland’s School of Mathematics and Physics, and Founder of the bioinformatics company Neuromathix (NeuroTech Research Pty Ltd).
To view this article subscribe or purchase a yearly pass here.
